Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway

Table 1

Effects of Exe on FBG and serum lipid profiles after four weeks of treatment.

	Control	Model	Exe
FBG (mmol/L)	8.92 ± 1.87	15.62 ± 3.66	9.28 ± 1.74^###
TC (mmol/L)	9.12 ± 3.93	11.58 ± 4.07	5.25 ± 3.36^##
TG (mmol/L)	3.73 ± 1.63	4.97 ± 1.26	1.66 ± 0.62^###&

Data are expressed as (n = 7-8). , model versus control group; and , Exe versus model group; , Exe versus control group. Exe: exenatide; FBG: fasting blood glucose; TC: total cholesterol; TG: triglyceride.